background image

Paid Clinical Trials Chicago

Discover 2,316 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: 40 recruiting locations
Sponsor: Celgene

Sex: Male

Age: 18+

Code: NCT06764485

Phase3, Recruiting
Active & Responsive

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

for
Relapsing Multiple Sclerosis (RMS)
Location: 61 recruiting locations
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06869785

Phase3, Recruiting
Active & Responsive

Home-based FES Training in People With Chronic Stroke

for
Chronic Stroke
Location: 1 recruiting location
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 70+

Code: NCT05849532

Recruiting
Active & Responsive

Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

for
Invasive Fungal Infection
Location: 1 recruiting location
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 2

Code: NCT04665037

Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

for
Small Cell Lung Cancer
Location: 8 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780137

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma
Location: 6 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05169515

Phase1, Recruiting
Active & Responsive

A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study

for
Multiple System Atrophy
Location: 16 recruiting locations
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Sex: All

Age: 30 - 70+

Code: NCT06568237

Phase2, Recruiting
Active & Responsive

An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)

for
Generalized Epidermolysis Bullosa Simplex
Location: 9 recruiting locations
Sponsor: TWi Biotechnology, Inc.

Sex: All

Age: 0+

Code: NCT06073132

Phase2, Phase3, Recruiting
Active & Responsive

Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.

for
Multiple Sclerosis
Location: 1 recruiting location
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT05516537

Recruiting
Active & Responsive

NVG-291 in Spinal Cord Injury Subjects

for
Spinal Cord Injuries, Chronic Spinal Cord Injury,
Location: 1 recruiting location
Sponsor: NervGen Pharma

Sex: All

Age: 18 - 70+

Code: NCT05965700

Phase1, Phase2, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago